Federal Circuit / U.S. Court of Spec. Jurisdiction

Custom text Title Organization
Dec
2
2021
Big Little Lies: Guidelines for Challenging Trademark Acquired Distinctiveness Claims McDermott Will & Emery
Dec
2
2021
Dispute on Arbitrability Needs an Arbitrator McDermott Will & Emery
Dec
2
2021
Disclaiming Patent Claims Leads PTAB to Grant a Request for Adverse Judgment Finnegan
Dec
1
2021
When (Patent) Success Isn’t Obvious Proskauer Rose LLP
Dec
1
2021
Patent Owner Loses Everything at PTAB Finnegan
Nov
29
2021
Federal Circuit Disinfects PTAB’s Obviousness Finding for MRSA Inactivation Patent Finnegan
Nov
23
2021
TTAB Issues Precedential Decision Holding that Reckless Disregard for Truth Satisfies the Requisite Intent for Fraud Polsinelli PC
Nov
22
2021
Who’s in Charge Here? Federal Circuit Says An Arbitrator, not District Court, Should Decide Arbitrability Mintz
Nov
18
2021
Juno v. Kite: Written Description and Claiming Antibodies and Chimeric Antigen Receptors—Lessons for Patent Prosecutors Proskauer Rose LLP
Nov
18
2021
Strathclyde v. Clear-Vu – A Class in Obviousness Schwegman, Lundberg & Woessner, P.A.
Nov
18
2021
No More Bites at the Apple: Imminent and Non-Speculative Standing Still Required McDermott Will & Emery
Nov
18
2021
Federal Circuit Clarifies Venue in Hatch-Waxman Case McDermott Will & Emery
Nov
15
2021
CosmoKey Gets a Duo-Over – Federal Circuit Panel Reverses Finding of Ineligibility Finnegan
Nov
15
2021
Federal Circuit Further Clarifies Venue in Hatch-Waxman Cases K&L Gates LLP
Nov
12
2021
Federal Circuit Affirms Dismissal of Hatch-Waxman Defendants for Lack of Venue and Failure to State a Claim Mintz
Nov
10
2021
Judge Leonard P. Stark Will Bring a Wealth of Patent Experience to the Federal Circuit Squire Patton Boggs (US) LLP
Nov
9
2021
Arbitration Clause Not Binding on the United States Patent Office Proskauer Rose LLP
Nov
8
2021
Formulation and Administration Claims Asserted in Hatch-Waxman Pass Muster Finnegan
Nov
6
2021
Patent Case Law Updates – November 2021 von Briesen & Roper, s.c.
Nov
4
2021
A Reminder of Doctrine of Equivalents in Biotechnology: Jennewein Biotechnologie GmbH v. International Trade Commission Proskauer Rose LLP
Nov
4
2021
Standing Challenge Brews Trouble in Trademark Dispute McDermott Will & Emery
Nov
2
2021
Beer Dispute Still Brewing: Federal Circuit Ruling Leaves Fate of BROOKLYN BREW SHOP Mark Partially Undecided Finnegan
Nov
1
2021
Federal Circuit Boots Potential Circuit Split as Trademark Case Turns Ugg-ly for Australian Boot-Maker Bracewell LLP
Nov
1
2021
Spotlight on Upcoming Oral Arguments - November 2021 Finnegan
Oct
28
2021
Design Patent Claims Limited to Recited Article of Manufacture Finnegan
Oct
28
2021
This Case Is Both Hot and Exceptional—Attorneys’ Fees and Inequitable Conduct McDermott Will & Emery
Oct
26
2021
Federal Circuit Clarifies that Willful Infringement Does Not Require Egregious Conduct Mintz
Oct
21
2021
Means-Plus-Function Claims: Don’t Forget the “Way” McDermott Will & Emery
Oct
21
2021
NDA Forum Selection Clause Doesn’t Bar IPR in Response to Subsequent Infringement Suit McDermott Will & Emery
Oct
21
2021
PTO’s Financial Benefits from IPR Don’t Render PTAB Unconstitutional McDermott Will & Emery
Oct
21
2021
Update: Absent Explicit Statutory Language? The American Rule Still Applies McDermott Will & Emery
Oct
14
2021
Authentication Claim Under Alice—A Two-Step Process McDermott Will & Emery
Oct
14
2021
Design Patent Prior Art Must Be From Same or Analogous Field as Claimed Article of Manufacture McDermott Will & Emery
Oct
14
2021
Ex Parte Reexamination Not Allowed After Failed IPR Challenge McDermott Will & Emery
Oct
14
2021
Failing to Address All Reasons for Noninfringement Renders Appeal Moot McDermott Will & Emery
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins